Riskpilot← Back to searchSign inGet full accessSinordica AB
ABActiveOrg 5592756950Grevgatan 40Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20200 employees
Revenue 2025
—
EBITDA margin
—
Equity ratio
89.9%
Financial strength
Net profit 2025
SEK 0
0 employees
| Revenue | — | — |
| EBITDA | — | — |
| Net profit | SEK 0 | — |
| Total assets | SEK 25K | +0% |
| Equity | SEK 22K | +0% |
| Employees | 0 | — |
Legal name
Sinordica AB
Org number
5592756950
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
8 oktober 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska bedriva handel inom medicinsk utrustning, hälsoprodukter och konsultverksamhet inom affärsutveckling i området.
Address
Grevgatan 40
Email
sunshujing@yahoo.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | — | — | — | — |
| Staff expenses | — | — | — | — | — |
| EBITDA | −2 | −1 | — | — | — |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −2 | −1 | 0 | — | — |
| Net financials | — | −0 | — | — | — |
| Profit before tax | −2 | −1 | 0 | — | — |
| Tax | −0 | — | — | — | — |
| Net profit | −2 | −1 | 0 | 0 | 0 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 25 | 25 | 25 | 25 | 25 |
| Equity | 23 | 22 | 22 | 22 | 22 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 2 | 3 | 3 | 3 | 3 |
| Total debt | 2 | 3 | 3 | 3 | 3 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20212025
Equity ratio
89.9%
This company
38.2%
Market median
+135% vs market
20212025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20212025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SS Chief Executive Officer | Chief Executive Officer | 2022 |
JS Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Sinordica AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Suzanne Shujing Sun | Chief Executive Officer | 0 companies |
| Jonas Sten Erik Hellberg | Deputy Chief Executive Officer | 0 companies |